Clinical Trial Update: Effects of Intact and Hydrolyzed Pea Protein on Food Intake, Glycemic Response and Subjective Appetite [Phase 1]

View source ↗

Summary

Phase 1 trial assessing the effects of intact and hydrolyzed pea protein on food intake, glycemic response, and subjective appetite. The study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Obesity

Drugs mentioned

• Hydrolyzed pea protein (pea protein hydrolysate)
• Intact pea protein (pea protein isolate)

Snippet

Sponsor: University of Toronto | Conditions: Diabetes Prevention, Obesity Prevention | Phase 1 | Status: COMPLETED